Weight reduction is not a major reason for improvement in rheumatoid arthritis from lacto-vegetarian, vegan or Mediterranean diets
© Sköldstam et al; licensee BioMed Central Ltd. 2005
Received: 04 October 2004
Accepted: 04 May 2005
Published: 04 May 2005
Several investigators have reported that clinical improvements of patients with rheumatoid arthritis (RA), from participating in therapeutic diet intervention studies, have been accompanied by loss of body weight. This has raised the question whether weight reduction per se can improve RA. In order to test this hypothesis, three previously conducted diet intervention studies, comprising 95 patients with RA, were pooled. Together with Age, Gender, and Disease Duration, change during the test period in body weight, characterised dichotomously as reduction or no reduction (dichoΔBody Weight), as well as Diet (dichotomously as ordinary diet or test diet), were the independent variables. Dependent variables were the difference (Δ) from baseline to conclusion of the study in five different disease outcome measures. ΔESR and ΔPain Score were both characterised numerically and dichotomously (improvement or no improvement). ΔAcute Phase Response, ΔPhysical Function, and ΔTender Joint Count were characterised dichotomously only. Multiple logistic regression was used to analyse associations between the independent and the disease outcome variables.
Statistically significant correlations were found between Diet and three disease outcome variables i.e. ΔAcute-Phase Response, ΔPain Score, and ΔPhysical Function. Δ Body Weight was univariately only correlated to ΔAcute-Phase Response but not significant when diet was taken into account.
Body weight reduction did not significantly contribute to the improvement in rheumatoid arthritis when eating lacto-vegetarian, vegan or Mediterranean diets.
KeywordsRheumatoid Arthritis therapy diet intervention lacto-vegetarian diet vegan diet Mediterranean diet body weight
We have recently found that patients with rheumatoid arthritis (RA) improved significantly in disease activity from eating a modified Cretan Mediterranean diet (MD) . Improvement was seen in 9 of 14 efficacy variables. The RA disease activity as measured by the "Disease Activity Score" DAS28  was reduced by 13 %. In comparison the control group showed no change. The favourable outcome of the diet intervention group indicated that the MD had been suppressive to RA inflammation. We believe that the anti inflammatory effect of the MD was mediated by its different lipid profile  in conjunction with its high content of fresh fruits and green vegetables. However, at the end of the experiment the patients of the MD group, but not the control group, had lost 3 kg in weight (p < 0.001 between groups), although our ambition had been to prescribe a diet that was isocaloric compared to the patients' previous food intake. This unexpected weight loss raised the question whether a reduced energy intake, could have been yet another anti-inflammatory factor? That diet intervention studies may induce unexpected weight reduction to patients with RA is a finding shared by others [3–9]. Some researchers [7, 8] have even reported a statistically significant correlation between change in body weight with change in arthritis measurements.
The aim of the present study was to investigate whether weight reduction could have anti inflammatory effect on RA. Data from three previously performed diet intervention studies were pooled for the analysis.
Two studies (1st and 3rd) had a prospective, randomised, and parallel design. The 2nd was a prospective, cross over study. Nor the participating patients or the clinical outcome valuators were blinded with respect to the study designs.
Baseline characteristics of patients who completed the trials.
Diet group (n = 60)
Control group (n = 42)
Disease duration (years)
The original studies
In the first study  24 RA patients concluded the trial. 14 tested a lacto-vegetarian diet, and 10 were controls. Eight from the diet group reported less pain at the end of the experiment. As a group they lost 2.6 kg (p < 0.001) in body weight, but showed no statistically significant change in disease outcome measures. The control group stayed unchanged.
In the second study , which had a cross over design, 20 RA patients concluded the trial. All were initially followed for a control period of two or five months, 13 and 7 patients, respectively. Thereafter, all patients adopted a vegan diet for 4 months. During the vegan diet period the group of 20 patients obtained statistically significant reduction in pain score, increase in functional capacity, and a loss of 4.8 kg (p < 0.001) in body weight. No change took place during the control periods. Only those 7 patients who had had a five months long control period were included as controls in the present pooled analysis.
In the third study  51 RA-patients concluded the trial. 26 tested a Cretan Mediterranean diet (MD) and 25 were controls. As a group the MD patients improved in 9 out of 14 disease outcome measures and lost 3 kg (p < 0.001) in body weight.
The pooled patient material
Number of patients from the three studies is 95. Seven of these patients were studied in a cross-over design (2nd study), and therefore, included both in the control and the intervention group giving a total number of 95+7. The patient demographics are shown in Table 1.
Five different measures of RA disease activity were identified, that had been assessed in all three studies. Two had been identically assessed in all three studies. These were the ESR (the Westergren erythrocyte sedimentation rate), and the Pain Score, which was the patient's self perceived pain severity as evaluated on a visual analogue scale (VAS, 0–100 mm).
The three measures, which were not similarly assessed and therefore not directly comparable, were firstly the blood plasma Acute-Phase Response , which in the 1st study was measured with the reaction in plasma concentration of orosomucoid, and in the 2nd and 3rd with the corresponding reaction of C-reactive protein (CRP). The second was Physical Function as evaluated and recorded by the patient with a graded questionnaire of difficulties in performing specified tasks of daily living. A locally constructed questionnaire was used in the 1st study, a not validated Swedish version of the Stanford-health assessment questionnaire (HAQ) in the 2nd study, and the official Swedish version of HAQ  in the third study. The third dissimilarly assessed outcome measure was the Tender Joint Count , which in the 1st study was the Ritchie joint index , and in the 2nd and 3rd study was the number of tender joints from palpation of 40, and 28 peripheral joints, respectively.
Due to different techniques of assessing these last three measures, change (Δ) obtained with these variables from baseline to the end of the experiments, could not be directly compared from the numerical results. These changes had to be converted into dichotomous values to enable a relevant statistical analysis. Change from baseline to the end of each study was thus characterised as improvement, or no improvement. These dichotomous variables are here called: dichoΔAcute-Phase Response, dichoΔPhysical Function and dichoΔTender Joint Count.
Gender, age and disease duration were used as independent variables. Age was characterised with respect to the median value, dichotomously, as <56 yrs or ≥ 56 yrs (dichoAge). Similarly, disease duration was characterised as <9.5 yrs or ≥ 9.5 yrs (dichoDisease Duration). Also the diet intervention was handled as an independent variable, and was characterised dichotomously, either as Case (lacto-vegetarian, vegan diet and Mediterranean) or as Control. The only independent outcome variable was the difference (Δ) from baseline to end of the study in body weight, and was characterised dichotomously as reduction or no reduction (dichoΔBody Weight).
Disease outcome variables
For evaluating effects that the dietary interventions might have had on RA disease activity, the difference (Δ) from baseline to end of study, in each of the five disease measures was calculated. For ESR and for Pain Score this was done numerically (numΔESR and numΔPain Score) but also, in the logistic regression, dichotomously characterised as improvement, or no improvement (dichoΔESR and dichoΔPain Score, respectively).
The other three RA disease measures were only handled dichotomously. They were: dichoΔAcute-Phase Response, dichoΔPhysical Function and dichoΔTender Joint Count, and were characterized as improvement /no improvement.
Baseline characteristics of the two diet groups were tested with non parametric tests (Mann-Whitney's U-test, and for gender Fischer's exact test; Table 1). Student's t-test and Mann-Whitney's nonparametric U-test were used to analyse group differences of change in numerical values of ΔESR and ΔPain Score, respectively.
The dichotomous variables were only analysed with logistic regression. All independent variables considered potentially significant were initially included in the model followed by a step-wise deletion of the least significant variable until a significant level of 0.05 or less. The statistical analyses were made using a commercially available computer programme (STATISTICA, StatSoft®, Tulsa, USA) and a p-value less than 0.05 was considered statistically significant.
Baseline values before diet intervention
At baseline, no significant differences in Age, Gender, Body Weight or Disease Duration were found between the two groups (Table 1) or in the disease measures ESR and Pain Score.
Change obtained from baseline to the end of the diet intervention period
Univariate logistic regression results (Odds Ratios (OR) and corresponding p-values), showing the associations between Gender, Age, Diet, Disease Duration and ΔBody Weight on the one hand, and the five different dichoΔ outcome variables on the other. Bolded values are statistically significant.
ΔPain Score showed a decrease of 10 units for the diet group and an increase of 2 units for the control group. This difference between groups was statistically significant (p = 0.011; Mann-Whitney's U-test) and was confirmed with the dichoΔPain Score difference (p = 0.007) (Table 2).
Using logistic regression, there were statistically significant correlations between diet and the results from three outcome variables. These were the dichoΔAcute-Phase Response, the dichoΔPain Score and the dichoΔPhysical Function, but not with the dichoΔESR or the dichoΔTender Joint Count (Table 2).
Multiple logistic regression results (Odds ratios (OR) and 95% confidence intervals(95% CI)), showing the association between the only statistically significant independentvariable, diet on the one hand, and the three disease outcome variables, which showedstatistically significant correlation to type of diet, on the other.
1.39 – 7.67
1.49 – 7.93
1.73 – 10.3
The time intervals between the 1st and 2nd, and between the 2nd and 3rd studies were approximately ten years. One of the authors was local clinical research coordinator for all three projects. The studies were conducted in three different regions of Sweden. However, the patient populations were very much alike, as all patients were recruited from similar clinical settings at the central out patient rheumatology clinic of each region.
In all three studies the patients had been aggressively treated pharmacologically according to the internationally recommended guidelines that were prevailing at the time of each study. As a consequence of the more efficient disease modifying drugs of the 1990ths, the arthritis activity was better controlled in the 3rd study than in the two earlier studies. With all three studies the participating patients had showed active interest for the kind of diet that was under investigation. At the time of the first two studies, vegetarian diets were advocated by laymen, while in the 1990ths much attention was focused on Mediterranean diets. Although different, these three diets shared some common characteristics which we believe were of importance with respect to control of inflammation. Compared to ordinary western diets they contained less of saturated fats from meat and dairy products. They had more of fresh fruits and of green vegetables. The MD was also rich in fats from sea foods, which was not a feature of the two vegetarian variants.
Another consequence of the time difference between the three studies was that the RA measures were not completely identical. They had successively been changed in line with the international recommendations of good scientific standards. Thus, comparable absolute baseline estimations of pain-score, acute phase response, physical function or tender joint count were not available due to their different definitions during the three intervention studies. Nevertheless, as explained in "methods", for the present analysis the outcome results of these variables were well defined, as they were dichotomously characterised as improvement, or no improvement.
The cross over design of the 2nd study, with 7 patients assessed first as controls and later as diet patients, weakens the statistical power of the pooled statistical analysis only marginally.
In the three studies of ours each intervention i.e. with lacto-vegetarian, vegan or modified Cretan Mediterranean diet had rendered the patients a weight fall of on the average 2.4 kg over a trial length of 3–4 months. In the pooled analysis of change in body weight versus change in clinical outcome measurements the results were fairly clear. Apart from a univariate correlation between improvement in acute phase response and reduction in body weight, no statistically significant correlation was seen with the multiple logistic regression analysis between weight loss and the concomitantly obtained change in RA disease measurements. Thus the body weight loss seemed to have had no statistical significant anti inflammatory effect. However, although the number of patients was increased from pooling three different studies, the total amount of data was still relatively small. Therefore a possible anti inflammatory effect of weight reduction should not be completely discarded. Furthermore, the potential effect that weight reduction may have, should ideally be studied by itself, i.e. the test and control diets should differ only with respect to their contents of energy.
As for comparison of diet intervention versus control diet, the multiple logistic regression analysis, showed highly significant statistical correlations between diet intervention and improvement in RA outcome variables. These data indicate that dietary factors may have a potential role in treatment of RA. With regards to vegan diets, our observation is supported by the results of at least two independent, randomised and controlled studies [6, 9].
Of course, the beneficial factors that the tested diets share need to be identified. A noteworthy candidate is their relatively low content of saturated fats . Another is their high content of fresh fruits and vegetables.
Patients with active RA tend to have an abnormally increased peripheral insulin resistance . Deliberate weight reduction in a group of patients with gout  was accompanied by reduction of insulin resistance and less numbers of inflammatory events. Whether this strategy for gout would work for patients with RA, and improve their arthritis, is an important clinical question. Some recent observational data indicate that overweight and obesity might be a risk factor for RA . From experimental studies in mice  it is known that long-term pure energy under-nutrition has anti-inflammatory effects. In humans, deliberately undertaken short term fasting is well known to induce immune suppression and improvement in RA disease activity . There are no controlled long-term studies of reduced energy intake without mal-nutrition on patients with RA. However, Iwasahige et al.  recently conducted a regiment for 54 days of caloric restriction combined with fasting in ten patients with RA. The patients lost in weight, and interestingly, the composite disease activity score of Lansbury was significantly reduced.
We know of two other small studies on deliberately undertaken weight reduction in patients with RA. In an uncontrolled pilot study  with 19 overweight patients with RA, Danish researchers had instructed the patients to lower their energy intake by 30% to achieve weight reduction. After a period of 12 weeks, the mean weight loss was 4.5 kg. No change was obtained in joint pain, morning stiffness, number of tender joints, or in sedimentation rate. Neither did Gordon et al. from their uncontrolled pilot study report any short-term favourable effects from assisting obese RA patients to reduce their body weight .
In conclusion, it seems as weight reduction strategies have little if any influence on RA inflammation. Perhaps this is not surprising with regards to what is already known from research on the metabolic syndrome and on atherosclerotic vascular disease, where isolated overweight is rank as a less important factor of risk .
Before conclusion of this discussion we need to remember that there is a controversy in letting patients with RA test an experimental regiment, which would involve prolonged reduction of their energy intake. During the course of RA most RA patients including those with overweight will develop a muscle wasting condition known as rheumatoid cachexia . Although not directly fatal, this form of cachexia is believed to contribute to co-morbidity and reduced life expectancy. It is caused by the rheumatoid inflammation by itself and is refractory to nutritional therapy.
- Sköldstam L, Hagfors L, Johansson G: Rheumatoid arthritis and Mediterranean diet. EULAR Ann Rheum Dis. 2003, 62: 208-214. 10.1136/ard.62.3.208.View Article
- Riel PL, van Gestel AM: Clinical outcome measures in rheumatoid arthritis. Ann Rheum Dis. 2000, 28-31. 10.1136/ard.59.suppl_1.i28. Suppl 59i
- Sköldstam L, Larsson L, Lindström FD: Effects of fasting and laktovegetarian diet on rheumatoid arthritis. Scand J Rheumatol. 1979, 8: 249-255.View Article
- Sköldstam L: Fasting and vegan diet in rheumatoid arthritis. Scand J Rheum. 1986, 15: 219-221.View Article
- Darlington LG, Ramsey NW, Mansfield JR: Placebo-controlled, blind study of dietary manipulation therapy in rheumatoid arthritis. Lancet. 1986, 1: 236-238. 10.1016/S0140-6736(86)90774-9.View Article
- Kjeldsen-Kragh J, Haugen M, Borchgrevink CF, Laerum E, Eek M, Mowinkel P, Hovi K, Førre Ø: Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet. 1991, 338: 899-902. 10.1016/0140-6736(91)91770-U.View Article
- Hansen GV, Nielsen L, Kluger E, Thysen M, Emmertsen H, Stengaard-Pedersen K, Hansen EL, Unger B, Andersen PW: Nutritional status of Danish rheumatoid arthritis patients and effects of diet adjustment in energy intake, fish-meal, and antioxidants. Scand J Rheumatol. 1996, 25: 325-330.View Article
- Sarzi-Puttin P, Comi D, Boccassini L, Muzzupappa S, Turiel M, Panni B, Salvaggio A: Diet therapy for rheumatoid arthritis. Scand J Rheumatol. 2000, 29: 302-307. 10.1080/030097400447688.View Article
- Hafström I, Ringertz B, Spångberg A, von Zweigbergk L, Brannemark S, Nylander I, Rönnelid J, Laasonen L, Klareskog L: A vegan diet free of gluten improves the signs and symptoms of rheumatoid arthritis: the effects on arthritis correlate with a reduction in antibodies to food antigens. Rheumatology. 2001, 40: 1175-1179. 10.1093/rheumatology/40.10.1175.View Article
- Emery P, Luqmani R: The validity of surrogate markers in rheumatic disease. Br J Rheumatol. 1993, 32 (Suppl 3): 3-8.View Article
- Ekdahl C, Eberhardt K, Andersson SI, Svensson B: Assessing disability in patients with rheumatoid arthritis: use of a Swedish version of the Stanford-Health Assessment Questionnaire. Scand J Rheumatol. 1988, 17: 263-271.View Article
- Ritchie DM, Boyle JA, McInnnes JM, Jasani MK, Dalakos TG, Grieveson P, Buchanan WW: Clinical studies with an articular index for the assessments of joint tenderness in patients with rheumatoid arthritis. Q J Med. 1968, 147: 393-406.
- Adam O, Beringer C, Kless C, Lemmen C, Adam A, Wiseman M, Adam P, Klimmek R, Forth W: Anti-inflammatory effects of a low arachidonic acid diet and oil in patients with rheumatoid arthritis. Rheumatol Int. 2003, 23: 27-36.
- Svensson KLG, Lundqvist G, Wide L, Hällgren R: Impaired Glucos handling in active rheumatoid arthritis: effects of corticosteroids and rheumatic treatment. Metabolism. 1987, 36: 944-948. 10.1016/0026-0495(87)90129-6.View Article
- Dessein PH, Shipton AE, Joffe BI, Ramokgadi J: Beneficial effects of weight loss with moderate calorie / carbohyudrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study. Ann Rheum Dis. 2000, 59: 539-543. 10.1136/ard.59.7.539.View Article
- Symmons DPM, Bankhead CR, Harrison BJ, Brennan P, Barrett EM, Scott DG, Stilman AJ: Blood transfusion, smoking, and obesity as risk factors for the developement of rheumatoid arthritis: results from a primary care-based incident case control study in Norfolk, England. Athritis Rheum. 1997, 40: 1955-1961.View Article
- Hart RW, Dixit R, Seng J, Turturro A, Leakey JE, Feuers R, Duffy P, Buffington C, Cowan G, Lewis S, Pipkin J, Li SY: Adaptive role of caloric intake on the disease processes. Toxicological Science. 1999, 3-12. Suppl 52
- Fraser DA, Thoen J, Reseland JJ, Førre Ø, Kjeldsen-Kragh J: Decreased CD4+ lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvation. Clin Rheumatol. 1999, 18: 394-401. 10.1007/s100670050125.View Article
- Iwashige K, Kouda K, Kouda M, Horiuchi K, Takahashi M, Nagano A, Tanaka T, Tacheuchi H: Calorie restricted diet and urinary pentosidine in patients with rheumatoid artritis. J Physiol Anthropol Appl Human Sci. 2004, 23 (1): 19-24. 10.2114/jpa.23.19.View Article
- Engelhart M, Kondrup J, Hoie LH, Andersen V, Kristensen JH, Heitmann BL: Weight reduction in obese patients with Rheumatoid Arthritis with preservation of body cell mass and improvement of physical fitness. Clin Exp Rheumatol. 1996, 14: 289-293.
- Gordon MM, Thomsson EA, Madhok R, Capell H: Can intervention modify adverse lifestyle variables in a rheumatoid population? Results of a pilot study. Ann Rheum Dis. 2002, 61: 66-69. 10.1136/ard.61.1.66.View Article
- Haapanen-Niemi N, Vouri I, Pasanen M: Public health burden of coronary heart disease risk factors among middle aged and elderly men. Prev Med. 1999, 28: 343-348. 10.1006/pmed.1998.0426.View Article
- Walsmith J, Roubenoff R: Cachexia in rheumatoid arthritis. Int J Cardiol. 2002, 85: 89-99. 10.1016/S0167-5273(02)00237-1.View Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.